Description
DEFINITY PERFLUTREN LIPID MICROSPHERE INJ, 2ML.
First action · last action
2015-01-09 · 2015-01-09
Transactions
1
First transaction's obligation
$120,603
Base + all options value (sum of deltas)
$120,603
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P2234D
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-01-09+$120,603= $120,603
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-01-09 | +$120,603 | $120,603 | DEFINITY PERFLUTREN LIPID MICROSPHERE INJ, 2ML. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI ZBTPKVDXCKJ7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24426F0334 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $306,741 | FY2026 |
| 36C24922N0132 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $26,416 | FY2022 |
| 36C25821P0312 | 258-NETWORK CNTRCT OFF 22G (36C258) · 6505 · DRUGS AND BIOLOGICALS | $101,384 | FY2021 |
| 36C24921F0037 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · Q527 · MEDICAL- NUCLEAR MEDICINE | $26,662 | FY2021 |
| 36C26121P0008 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $0 | FY2021 |
| 36C24920F0011 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $23,667 | FY2020 |
Other recipients under 6505 from 256-NETWORK CONTRACT OFFICE 16 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25616P0619 | BIOCOMPATIBLES, INC. | 256-NETWORK CONTRACT OFFICE 16 | $147,500 | FY2016 |
| VA25616F0536 | RETURNS 'R' US, LLC | 256-NETWORK CONTRACT OFFICE 16 | $0 | FY2016 |
| VA25616E3628 | MCKESSON CORPORATION | 256-NETWORK CONTRACT OFFICE 16 | $17,878,985 | FY2016 |
| VA25616P0541 | MCKESSON PLASMA AND BIOLOGICS LLC | 256-NETWORK CONTRACT OFFICE 16 | $10,851 | FY2016 |
| VA25616P0522 | BIOCOMPATIBLES, INC. | 256-NETWORK CONTRACT OFFICE 16 | $32,000 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25615F0367_3600_V797P2234D_3600 · retrieved 2026-09-26.